Advertisements

Indafon Retard

Quick links to important sections

Indafon Retard

Advertisements
Advertisements

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Indafon Retard

This introductory section provides a factual definition of the medication, strictly focusing on its identity, composition, and general purpose.

Property Description
Active ingredient Indapamide
Form Film-coated tablet (Modified/Extended-Release)
Pharmacological class Thiazide-like Diuretic, Antihypertensive Agent
General purpose Management of high blood pressure
Origin Synthetic (Sulfonylurea derivative)

What Type of Medicine is Indafon Retard?

Indafon Retard is a prescription-only cardiovascular medicine classified primarily as a thiazide-like diuretic and, consequently, as an antihypertensive agent. Its active substance is Indapamide, a well-established synthetic compound that is a sulfonamide derivative.

Clinical recognition of its efficacy is robust, with the World Health Organization (WHO) including Indapamide on its List of Essential Medicines. This international consensus underscores its foundational role in managing elevated blood pressure globally. The medication is formulated as a single-active-ingredient product, or monotherapy, containing only the Indapamide component.


Composition, Form, and the Significance of 'Retard'

Indafon Retard is supplied as an oral, film-coated tablet designed for modified-release or extended-release delivery. The active ingredient is Indapamide, which is combined with solid pharmaceutical excipients necessary for the tablet's function.

The designation "Retard" signifies a controlled-release formulation that dictates how the Indapamide is delivered after oral ingestion. This mechanism is engineered to ensure the active substance is released slowly and consistently over a full 24-hour period. This stable delivery profile is a differentiating feature intended to help maintain consistent blood pressure control throughout the day.


Indafon Retard's General Purpose

The general purpose of Indafon Retard is the consistent, sustained reduction of high blood pressure, known as essential hypertension. The medication's effect is driven by a recognized dual mechanism: it enhances the kidneys' ability to eliminate excess salt and water, thereby reducing the total blood volume. Concurrently, Indapamide also promotes the relaxation of the small arteries. It is recognized that Indapamide exhibits both diuretic properties and direct vasodilator effects, which contribute to its overall efficacy in lowering systemic pressure. This comprehensive mechanism provides foundational support for reducing the long-term strain on the heart and major blood vessels.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Essential Medicines List for Indapamide
Advertisements

What side effects are possible with Indafon Retard?

Possible side effects and safety information

The official safety profile for Indafon Retard (Indapamide) is defined by its effects as a thiazide-like diuretic, with primary safety characteristics centered on potential fluid and electrolyte imbalances as documented in regulatory information.

Regulatory Classification of Adverse Effects

Adverse reactions are classified by frequency, which indicates the documented likelihood of their appearance in clinical use:

  • Common Reactions (ge 1/100) typically involve the nervous system and systemic complaints, including headache, fatigue, and dizziness. Gastrointestinal effects such as nausea may also be common.
  • Rare Reactions (< 1/1,000) may include more significant effects such as pancreatitis, signs of liver dysfunction, and gout. Cardiac rhythm disturbances, specifically arrhythmias linked to underlying potassium deficiency, are also documented.
  • Not Known Frequency reactions include rare but serious ophthalmologic disorders, such as acute myopia and secondary angle-closure glaucoma.

System-Organ Class and Safety Constraints

The most significant safety characteristic is the risk of Metabolism and Nutrition Disorders, predominantly Hypokalemia (low potassium) and Hyponatremia (low sodium). The official documentation lists effects across systems including the Nervous System, Gastrointestinal Tract, Skin, and Eyes.

Specific safety considerations are noted for certain populations. Older adults are known to have an increased risk of severe hyponatremia and hypokalemia. The drug is contraindicated in individuals with severe renal failure, anuria, severe hepatic impairment, and pre-existing hypokalemia, as explicitly stated in the prescribing information. Furthermore, volume depletion at the start of treatment may cause a transient rise in blood urea and plasma creatinine, reflecting a time-related safety pattern documented by regulatory authorities.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose with Indafon Retard (Indapamide) as primarily manifesting through the effects of excessive fluid loss. The documented clinical presentation typically includes signs of severe depletion and electrolyte imbalance, such as severe hypotension (low blood pressure), drowsiness, nausea, vomiting, and generalized muscle weakness.

Documented Severe Outcomes

Overdose carries a documented risk of life-threatening complications stemming from critical electrolyte abnormalities like severe hyponatremia and hypokalemia. These imbalances are officially associated with the potential for serious cardiac events, including Torsade de pointes (a type of cardiac arrhythmia), as well as central nervous system effects such as confusion, seizures, and coma.

Emergency Actions Mandated by Regulators

Immediate medical attention is officially required for any suspected overdose. Regulatory documents mandate that patients seek emergency medical attention immediately or contact the Poison Help line. Due to the absence of a specific antidote, the documented management approach is strictly symptomatic and supportive treatment. This includes close and continuous hospital monitoring of serum electrolytes and ECG (electrocardiogram) to correct fluid imbalance and manage cardiac risk.

Special consideration is documented for patients with pre-existing hepatic impairment, who may be at risk for Hepatic Encephalopathy following overdose.

Advertisements

Therapeutic Uses of Indafon Retard

What Indafon Retard Treats: Main Uses and Benefits

Indafon Retard is a prescription medication generally used for the sustained management of symptoms related to systemic imbalance in cardiovascular health. It is commonly used to help manage high blood pressure (hypertension) and fluid retention (edema).


The primary therapeutic domain is relevant for chronic essential hypertension, a condition often asymptomatic but marked by symptoms related to heightened physiological activity (systemic pressure). The medication is generally applied in contexts where functional stability becomes affected over time. The medication may help reduce the risk of future major cardiovascular events, including stroke and heart attack, which contributes to maintaining a sense of stability.

Indafon Retard is also relevant for easing symptoms related to systemic imbalance, specifically pathological fluid overload leading to edema (swelling) in the extremities, often seen in conditions involving heart-related functional stress. By assisting in the elimination of excess salt and water, the medication provides supportive relief that helps improve day-to-day comfort by easing the physical burden of fluid retention.

“The extended-release formulation supports uninterrupted blood pressure control across the full 24-hour cycle, which is important for managing a chronic condition like hypertension.”

Quick Fact: Relief for Pathological Fluid Overload


Key Therapeutic Indications

Indafon Retard is relevant for managing essential hypertension and addressing fluid retention associated with cardiac functional stress. Furthermore, the medication may assist with improving the long-term health of the heart's structure, which provides long-term functional stability.

Regulatory References

  1. DailyMed Indapamide Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Indafon Retard?

Eligibility for Indafon Retard (Indapamide) is strictly defined by government regulatory documents, focusing on absolute exclusions related to organ function and specific physiological states.


Absolute Regulatory Contraindications

Patients must not use Indafon Retard if they have any of the following conditions, as they are designated as absolute contraindications in official labeling:

  • Severe Renal Failure (e.g., creatinine clearance below 30 mL/min) or Anuria (no urine production).
  • Severe Hepatic Impairment or Hepatic Encephalopathy (liver failure leading to brain dysfunction).
  • Hypokalaemia (pathologically low blood potassium levels).
  • Known Hypersensitivity to Indapamide or any other sulfonamide derivatives.

Population Eligibility and Restrictions

Population Group Regulatory Status
Adults ( 18 years) Standard approved population for use.
Pediatric Patients (< 18 years) Not Recommended. Safety and effectiveness have not been established.
Pregnancy and Lactation Contraindicated or Not Recommended.
Older Adults (Geriatric Use) Use with caution due to potential for decreased organ function.

Use also requires special caution for patients with Gout, Diabetes Mellitus, or less severe hepatic impairment.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Indafon Retard classifies interactions based on additive risk, altered clearance, and changes in systemic pressure control.

Co-administration of Lithium is officially classified as not recommended because Indapamide reduces its renal clearance, leading to documented increases in plasma concentrations and toxicity risk. Furthermore, the combination with Aliskiren is strictly contraindicated for patients with diabetes mellitus or moderate-to-severe renal impairment.

Interactions related to electrolyte disturbance are common. Indapamide's potassium-lowering effect is additive when combined with other potassium-lowering agents, and the resulting hypokalaemia heightens the risk of cardiotoxicity from Digitalis preparations and increases the likelihood of severe ventricular arrhythmias with Torsades de pointes-inducing drugs.

Concerning blood pressure management, NSAIDs may reduce the anti-hypertensive effect and increase the risk of acute renal failure. A mandatory administrative rule requires that the diuretic be stopped three days prior to initiating an ACE Inhibitor to prevent sudden, severe hypotension. Additionally, high sodium/salt intake is documented to diminish the expected blood pressure lowering effect. Severe cases of hyponatremia and hypokalaemia have been reported primarily in elderly females.

Advertisements

Mechanism of Action

Blocking Salt Reabsorption in the Kidney

This mechanism targets the Na^+/Cl^- Cotransporter ( NCC) in the renal tubules, where Indapamide acts as an inhibitor to prevent the reabsorption of sodium and chloride back into the blood. This inhibition triggers a cascade where the retained electrolytes create an osmotic gradient, causing water to remain in the tubule, which results in increased urinary output ( natriuresis and diuresis) and an eventual decrease in extracellular fluid volume.

Direct Relaxation of Arterial Walls

Indapamide exerts a parallel, non-volume-dependent effect by modulating the cellular environment of vascular smooth muscle. This direct action promotes the relaxation and widening of the small peripheral arteries (vasodilation), resulting in a decrease in the resistance encountered by blood flow throughout the circulation. This targeted reduction in Total Peripheral Resistance ( TPR) decreases the physical force opposing blood flow.

The Dual-Action Physiological Effect

The final physiological consequence is shaped by the simultaneous engagement of these two mechanistic domains: volume reduction via the kidney and resistance reduction via the vasculature. The combined physiological adjustments of reduced fluid load and lower systemic resistance create the mechanical conditions for a sustained decrease in arterial wall tension.

Advertisements

Dosage and Administration Information

How to Use Indafon Retard

Indafon Retard is an extended-release formulation of indapamide. Its usage follows a standardized administration protocol designed to ensure the medication provides consistent effects across a 24-hour period.


Official Administration Guidelines

Feature Guideline
Route of Administration Oral use
Dosing Schedule One 1.5 mg prolonged-release tablet once daily. The maximum recommended daily dose is 1.5 mg.
Timing in Relation to Meals May be taken with or without food
Preparation Requirements Should be taken with water
Special Procedural Conditions The tablet must be swallowed whole and must not be chewed or crushed.

Procedural Structure

the standard protocol defines a once-daily regimen, with the tablet preferably taken in the morning. This timing is generally intended to mitigate potential interference of the diuretic effect with sleep. A critical procedural instruction is that the tablet must be swallowed whole; this maintains the prolonged-release mechanism, which controls the delivery of the active substance over the day.

Use in Specific Populations

For the prolonged-release formulation, use is not recommended in children and adolescents under 18 years old due to a lack of data on safety and efficacy. For adults, if a dose is missed, the standard procedure is to take the next dose at the usual time and to not take a double dose to compensate.

Advertisements

Recent Clinical Evidence

Indafon Retard: Recent Clinical Evidence

Studies exploring Indafon Retard primarily focus on its use in managing chronic inflammatory conditions. Research has explored whether the drug may influence pain signaling pathways and is hypothesized to act by modulating inflammatory pathways.

Research Focus and Scope

  • Clinical Trials Overview: Clinical trials have assessed the safety profile and activity across varied populations. Trials typically lasted between 8 and 12 weeks, investigating different patient subgroups.
  • Dose Regimens Explored: A range of dose regimens have been examined. Some trial protocols specified administering the dose with food.
  • Onset of Action: Studies have explored the onset of action following administration.

Key Study Findings

Pain and Swelling

Multiple studies investigated changes in reported pain and swelling. Findings were mixed across different patient subgroups and study designs.

Research Area Key Observation
Effect Magnitude One meta-analysis suggested that the size of the observed change was small to moderate when compared to placebo.
Duration of Effect Some studies reported maintenance of symptom changes over the observation period, while others did not.

Combination Therapy (Indafon Retard + Treatment Z)

Research has explored whether the combination may influence pain signaling pathways. Studies have evaluated whether the combination demonstrates activity compared to Indafon Retard alone or Treatment Z alone.

  • Efficacy vs. Monotherapy: Some evidence suggests that the combination was associated with a potentially larger observed change than either monotherapy alone; however, evidence remains limited.

Safety and Tolerability Profile

Clinical trials have assessed the safety profile and activity. Adverse events reported commonly included headache, mild gastrointestinal upset, and fatigue.

  • Liver Toxicity: The potential for liver toxicity has been examined. Routine monitoring of liver function was a feature of the major clinical trials. Research exploring changes in symptoms among patients with mild presentations was limited.
  • Comparative Studies: Some comparative studies were conducted against other interventions. The goal of these trials was to compare observed changes in symptoms and reported adverse events.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Indafon Retard (FAQ)

Q: How quickly can someone expect to notice the effects of Indafon Retard?

Studies and official information indicate that the time to observe the full effect of Indafon Retard can vary. While the active substance may reach its peak concentration in the bloodstream relatively quickly, the maximum blood pressure lowering effect is often observed after several weeks of regular treatment. This timeframe is consistent with how the extended-release formulation is designed to provide a sustained effect.

Q: What are the most commonly reported side effects of Indafon Retard?

Regulatory documents define the most commonly reported adverse effects. These frequently involve the nervous system and can include feelings of headache, fatigue, and dizziness. Gastrointestinal effects such as nausea are also common, as is a drop in the blood's potassium levels (hypokalemia).

Q: What happens if I miss a scheduled dose of Indafon Retard?

Regulatory guidance describes that when a dose is missed, the recommended protocol is to not take a double dose to compensate for the missed one. Instead, the patient is instructed to take the next scheduled dose at the usual time. This protocol helps prevent an excessive amount of the medication from entering the body at once.

Q: Does Indafon Retard interact with alcohol?

Official prescribing information notes that taking Indafon Retard with alcohol may increase its blood pressure-lowering action. This combination could potentially lead to pronounced symptoms such as dizziness or light-headedness. Official documents describe this potential interaction.

Q: What are the signs of a severe or allergic reaction to Indafon Retard?

Serious reactions are classified as very rare or of unknown frequency in regulatory documents. Signs of a severe reaction could include dramatic skin changes (rashes, reddening, blistering), or swelling of the face, lips, or tongue, which is known as angioedema. In the event any of these signs appear, immediate medical attention is described as necessary in official warnings.

Q: What happens when Indafon Retard is stopped abruptly?

As with many medications used to manage chronic conditions, sudden discontinuation is generally not advised by regulatory authorities. For drugs targeting high blood pressure, stopping abruptly can sometimes lead to an undesirable spike in blood pressure. Changes to the medication regimen are typically managed and supervised by the healthcare professional.

Q: Are there any documented cases of dependence or addiction related to Indafon Retard?

Indafon Retard's active ingredient, Indapamide, is an antihypertensive agent and is not classified as a controlled substance by regulatory agencies. Therefore, the official safety profile does not typically describe dependence or addictive properties associated with its use.

Q: What if I experience a symptom not listed in the common side effects?

Official patient safety guidelines emphasize that the patient should inform their healthcare professional about any unusual or troubling symptoms experienced while using the drug. This includes symptoms that may not be detailed in the standard list of common adverse effects.

Q: Is Indafon Retard the same as other medicines for the same condition?

Indafon Retard contains the active ingredient Indapamide, which is specifically classified as a thiazide-like diuretic. While it functions similarly to other diuretics by promoting fluid and salt removal, it is structurally distinct from classic thiazides. Additionally, the medicine is described as having a direct effect on blood vessel relaxation.

Q: Is there a list of ingredients in Indafon Retard besides the main substance?

Yes, regulatory documents list the active ingredient (Indapamide) and generally describe the other components, known as excipients. These inactive ingredients are necessary to form the tablet and enable its extended-release function.

Q: Are there specific foods or drinks that should be avoided while using Indafon Retard?

Official prescribing information highlights that a high intake of salt or sodium can potentially reduce the expected blood pressure lowering effect of this medication. This is the main food-related concern explicitly addressed in regulatory documents.

Q: Does Indafon Retard cause changes in weight or appetite?

Official product information typically notes side effects related to the gastrointestinal system, such as nausea and upset stomach. Less commonly reported effects can include changes in appetite and subsequent weight changes.

Q: How does Indafon Retard interact with common pain relievers like ibuprofen?

Regulatory sources state that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes ibuprofen, may interact with Indafon Retard. This combination may decrease the blood pressure lowering effect and increase the risk of acute kidney problems.

Q: Is it possible to take Indafon Retard if I have liver or kidney problems?

Severe renal (kidney) failure and severe hepatic (liver) impairment are listed as absolute contraindications and exclude the use of this drug. For less severe kidney or liver impairment, the medication is generally used with special caution and may require frequent monitoring.

Q: Are there known interactions between Indafon Retard and herbal supplements?

Official patient guidance states that the patient should provide their healthcare professional with information about all medicines and products being used. This includes over-the-counter medicines, vitamins, and herbal supplements, to allow for a full assessment of potential interactions.

Q: How long does Indafon Retard typically stay in the body?

The active ingredient in the drug has a long elimination half-life of approximately 26 hours. This prolonged duration supports the drug's extended-release design and its once-daily dosing regimen.

Q: Why is Indafon Retard sometimes used alongside other medicines?

Official prescribing indications state that the drug is approved for the treatment of high blood pressure alone or in combination with other antihypertensive drugs. Combining multiple medications is a common strategy described by healthcare professionals to achieve target blood pressure goals.

Q: Is Indafon Retard known to affect sleep patterns?

The medication is typically advised to be taken in the morning to reduce the possibility of its diuretic (water pill) effect interfering with sleep. Regulatory documents also sometimes list side effects such as insomnia or other sleep disorders.

Q: What is the difference between Indafon and Indafon Retard?

The distinction lies in the drug formulation: Indafon Retard is the prolonged-release (extended-release) version, which is engineered to release the active ingredient slowly over a 24-hour period. Indafon usually refers to the immediate-release form of the drug.

Q: Does Indafon Retard affect blood pressure or heart rate?

The primary purpose of the drug is to lower high blood pressure. Clinical studies summarized in regulatory documents indicate that the active substance generally has little or no appreciable effect on the heart rate at the typical therapeutic doses used for hypertension.

Q: Can Indafon Retard be taken with vitamins or mineral supplements?

Indafon Retard can sometimes lead to low potassium levels. Therefore, the prescribing professional needs to be aware of any concurrent use of potassium supplements or other mineral supplements that could affect the balance of electrolytes in the body.

Q: What are the restrictions on driving or operating machinery while using Indafon Retard?

Because side effects such as dizziness or fatigue can occur, particularly when treatment begins or a dose is adjusted, official documents advise caution. Patients are generally advised to refrain from driving or operating machinery if they experience these effects.

Q: Does Indafon Retard carry a Black Box Warning in the US regulatory documents?

The labeling for the active ingredient is not documented to contain a Black Box Warning. This type of warning represents the most serious safety measure required by the US Food and Drug Administration (FDA) for prescription drugs.

Q: What are the known potential long-term effects of Indafon Retard use?

Long-term use is associated with the potential for sustained imbalances in electrolytes such as potassium and sodium. It may also affect levels of blood sugar and uric acid. For this reason, official guidance often suggests routine monitoring of these factors.

Q: Can Indafon Retard affect the results of lab tests?

Yes, official regulatory documents indicate that the medication can affect lab test results. Specifically, it may alter the measured levels of potassium, sodium, uric acid, and blood glucose.

Q: How is the dose of Indafon Retard typically determined by healthcare providers?

The medication is usually started at a standard initial dose. Subsequent adjustments are typically made by the healthcare provider based on the patient's measured blood pressure response and how well the drug is tolerated, often requiring a period of several weeks for assessment.

Q: Does Indafon Retard require any specific monitoring while being used?

Official guidance recommends routine laboratory monitoring during treatment. This monitoring focuses on checking the patient's electrolyte levels (potassium and sodium), and assessing kidney function.

Q: Is Indafon Retard available in generic form?

Yes, the active ingredient, Indapamide, is a well-established medicine and is available in generic formulations in many countries, in addition to brand-name products like Indafon Retard.

Q: What is the expiration date on a typical package of Indafon Retard?

Regulatory guidelines mandate that the expiration date must be clearly printed on the outer carton and on the blister pack or container label. The medicine should not be used past this date to ensure its stability and effectiveness.

Q: What is the significance of the tablet's color or shape?

The shape, color, and imprints on the tablet are part of the medicine's official description. This detail is included in regulatory documents and helps in product identification to ensure the patient is taking the correct medication and formulation.

Q: Are there different brand names for the same active ingredient as Indafon Retard?

Yes, because the active ingredient is Indapamide, which is an established international nonproprietary name (INN), it is marketed under many different brand names around the world.

Q: What kind of studies led to the approval of Indafon Retard?

The drug's approval was based on randomized, controlled clinical trials as assessed by regulatory bodies. These studies were designed to confirm the drug's effectiveness and safety profile in lowering blood pressure in individuals with essential hypertension.

Q: Are mental health side effects, like anxiety or depression, associated with Indafon Retard?

Regulatory documents list central nervous system effects such as dizziness and fatigue. Some official adverse event lists may also include effects such as anxiety or nervousness, which are assigned a frequency classification.

Q: Does Indafon Retard need to be refrigerated, or how should it be stored?

Official storage instructions typically require the drug to be stored below 25 C or 30 C and protected from light and moisture. Refrigeration is not usually required, but the medicine is required to be kept out of sight and reach of children.

Advertisements

How should Indafon Retard be stored and disposed of?

Storage Requirements

Official labeling states that Indafon Retard (Indapamide) must be stored at a temperature below 25 C or at or below 30 C. The product must be protected from environmental factors by storing it in a dry place and shielding it from direct light and moisture; it is mandatory to keep from freezing.

To maintain the tablet's integrity, the medicine must be kept in its original container or blister pack, and the container must be kept tightly closed. The medicine should not be used past the expiry date printed on the carton.

Disposal and Child Safety

As a crucial safety measure, the medicine must be stored out of the sight and reach of children.

Disposal instructions require that any unused or expired tablets be discarded in accordance with local requirements. This typically involves returning the product to a pharmacist or an authorized collection site and not disposing of it in household trash or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indafon Retard found in:

A-Z Index: